0001857448-21-000001.txt : 20210505 0001857448-21-000001.hdr.sgml : 20210505 20210505142310 ACCESSION NUMBER: 0001857448-21-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20210505 DATE AS OF CHANGE: 20210505 EFFECTIVENESS DATE: 20210505 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Maxona Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001857448 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-398344 FILM NUMBER: 21892618 BUSINESS ADDRESS: STREET 1: 300 VILLAGE DRIVE STREET 2: SUITE 719 CITY: KING OF PRUSSIA STATE: PA ZIP: 19406 BUSINESS PHONE: 484.684.7737 MAIL ADDRESS: STREET 1: 300 VILLAGE DRIVE STREET 2: SUITE 719 CITY: KING OF PRUSSIA STATE: PA ZIP: 19406 D 1 primary_doc.xml X0708 D LIVE 0001857448 Maxona Pharmaceuticals, Inc. 300 VILLAGE DRIVE SUITE 719 KING OF PRUSSIA PA PENNSYLVANIA 19406 484.684.7737 DELAWARE None None Corporation true 2016 Shahin Fatholahi 300 Village Drive Suite 719 King of Prussia PA PENNSYLVANIA 19406 Executive Officer Director Behshad Sheldon 300 Village Drive Suite 719 King of Prussia PA PENNSYLVANIA 19406 Director David Nakamura 300 Village Drive Suite 719 King of Prussia PA PENNSYLVANIA 19406 Director Pharmaceuticals Decline to Disclose 06b false 2021-04-09 false true false 0 Arcadia Securities, LLC 44656 None None 1370 Avenue of the Americas, 29th Floor New York NY NEW YORK 10019 AK ALASKA AZ ARIZONA CA CALIFORNIA CO COLORADO CT CONNECTICUT FL FLORIDA IL ILLINOIS MD MARYLAND MA MASSACHUSETTS MI MICHIGAN NJ NEW JERSEY NY NEW YORK OR OREGON PA PENNSYLVANIA SC SOUTH CAROLINA TX TEXAS WY WYOMING false 10000000 5555000 4445000 false 34 502217 0 0 false Maxona Pharmaceuticals, Inc. /s/ Shahin Fatholahi Shahin Fatholahi Chief Executive Officer 2021-05-05